Low-Code Programming Models

Traditionally, computer programming has been the prerogative of professional developers using textual programming languages such as C, Java, or Python. Low-code programming promises an alternative: letting citizen developers create programs using visual abstractions, demonstrations, or natural language. While low-code programming is currently getting a lot of attention in industry, the relevant research literature is scattered, and in fact, rarely uses the term "low-code". This article brings together low-code literature from various research fields, explaining how techniques work while providing a unified point of view. Low-code has the potential to empower more people to automate tasks by creating computer programs, making them more productive and less dependent on scarce professional software developers

L'exposition aux moisissures des enfants en milieu citadin et rural

L'asthme est une des maladies chroniques des plus fréquentes chez l'enfant qui touche 7,6 à 10,7 % de la population infantile française (ISAAC, 1998). Un des facteurs étiologiques impliqué dans cette pathologie est les moisissures présentes dans l'habitat. Néanmoins, il reste toujours à clarifier quelle est la fenêtre d'exposition la plus critique au cours de l'enfance et à comprendre le mécanisme de cette étiologie. En effet, des effets contradictoires ont été associés à l'exposition précoce des enfants aux moisissures. L'exposition à une espèce de moisissure dominante augmente l'incidence de l'asthme chez le jeune enfant, alors que l'exposition à des bioaérosols riches et diversifiés en micro-organismes, comme ceux présent dans les fermes, le diminue. Ces deux effets font l'objet des deux études choisies dans cette note. [Auteure]]]> Asthma ; Child ; Respiratory Tract Diseases ; Fungi ; Rhinitis, Allergic, Perennial fre oai:serval.unil.ch:BIB_C31B6241296B 2022-05-07T01:26:31Z openaire documents <oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"> https://serval.unil.ch/notice/serval:BIB_C31B6241296B Long-acting antiretrovirals: a new era for the management and prevention of HIV infection. info:doi:10.1093/jac/dkab324 info:eu-repo/semantics/altIdentifier/doi/10.1093/jac/dkab324 info:eu-repo/semantics/altIdentifier/pmid/34499731 Thoueille, P. Choong, E. Cavassini, M. Buclin, T. Decosterd, L.A. info:eu-repo/semantics/review article 2022-02-02 The Journal of antimicrobial chemotherapy, vol. 77, no. 2, pp. 290-302 info:eu-repo/semantics/altIdentifier/eissn/1460-2091 urn:issn:0305-7453 <![CDATA[The long-acting antiretroviral cabotegravir and rilpivirine combination has just received FDA, EMA and Health Canada approval. This novel drug delivery approach is about to revolutionize the therapy of people living with HIV, decreasing the 365 daily pill burden to only six intramuscular injections per year. In addition, islatravir, a first-in-class nucleoside reverse transcriptase translocation inhibitor, is intended to be formulated as an implant with a dosing interval of 1 year or more. At present, long-acting antiretroviral therapies (LA-ARTs) are given at fixed standard doses, irrespectively of the patient's weight and BMI, and without consideration for host genetic and non-genetic factors likely influencing their systemic disposition. Despite a few remaining challenges related to administration (e.g. pain, dedicated medical procedure), the development and implementation of LA-ARTs can overcome long-term adherence issues by improving patients' privacy and reducing social stigma associated with the daily oral intake of anti-HIV treatments. Yet, the current 'one-size-fits-all' approach does not account for the recognized significant inter-individual variability in LA-ART pharmacokinetics. Therapeutic drug monitoring (TDM), an important tool for precision medicine, may provide physicians with valuable information on actual drug exposure in patients, contributing to improve their management in real life. The present review aims to update the current state of knowledge on these novel promising LA-ARTs and discusses their implications, particularly from a clinical pharmacokinetics perspective, for the future management and prevention of HIV infection, issues of ongoing importance in the absence of curative treatment or an effective vaccine

Avancées sur la source, la taille et la nature des particules microbiennes aéroportées présentes dans l'environnement intérieur

L'exposition à certaines particules fongiques et bactéries présentes dans les aérosols de l'environnement intérieur a été associée au développement ou à l'exacerbation d'affections respiratoires telles que l'asthme, la rhinite allergique ou encore l'aspergillose (1-4). Le réservoir principal identifié dans cet environnement pour les bactéries aéroportées est constitué par les habitants eux-mêmes, alors que celui des particules fongiques est l'environnement extérieur, ou, lorsque les conditions sont réunies, l'environnement intérieur (5-7). Néanmoins, la nature et la taille de ces particules fongiques, ainsi que l'impact de l'occupation humaine sur ces paramètres n'ont été que peu explorés. Les articles de cette note s'intéressent justement à ces aspects et illustrent l'importance de leur prise en compte dans l'évaluation du risque d'exposition aux microorganismes dans l'environnement intérieur. L'étude de Hospodsky et coll. (2014) apporte une information quantitative sur le niveau d'émission de bactéries et particules fongiques résultant d'une occupation humaine dans des environnements intérieurs sains. Alors que l'étude de Afanou et coll. (2014) montre la complexité des particules fongiques qui peuvent être générées dans l'environnement intérieur, différentes espèces de moisissures pouvant participer en proportions différentes au nombre de particules submicroniques1 grâce à leurs fragments de spores ou hyphes

Latest Trends in Pollutant Accumulations at Threatening Levels in Energy-Efficient Residential Buildings with and without Mechanical Ventilation: A Review

Improving the energy efficiency of buildings is a major target in developed countries toward decreasing their energy consumption and CO2 emissions. To meet this target, a large number of countries have established energy codes that require buildings to be airtight. While such a retrofitting approach has improved health outcomes in areas with heavy traffic, it has worsened the health outcomes in Nordic countries and increased the risk of lung cancer in areas with high levels of radon emissions. This review highlights the importance of adapting the characteristics of energy-efficient residential buildings to the location, age, and health of inhabitants to guarantee healthy indoor pollutant levels. The implementation of mechanical ventilation in new energy-efficient buildings has solved some of these problems; however, for others, a decrease in the level of outdoor pollutants was still required in order to achieve a good indoor air quality. A good balance between the air exchange rate and the air humidity level (adapted to the location) is key to ensuring that exposure to the various pollutants that accumulate inside energy-efficient buildings is low enough to avoid affecting inhabitants′ health. Evidence of the protective effect of mechanical ventilation should be sought in dwellings where natural ventilation allows pollutants to accumulate to threatening levels. More studies should be carried out in African and Asian countries, which, due to their rapid urbanization, use massive volumes of unproven/unrated building materials for fast-track construction, which are frequent sources of formaldehyde and VOC emissions